ReviewInternational journal of molecular sciences2026

Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity.

Ilaria Mariangela Scaglione et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.